Key result
Gabapentin resolves paroxysmal sympathetic hyperactivity in a cardiogenic shock patient without brain injury.
Why the study?
Paroxysmal sympathetic hyperactivity is typically seen after severe brain injury and has not previously been reported in association with cardiogenic shock.
Paroxysmal sympathetic hyperactivity can occur in cardiogenic shock due to cerebral perfusion disturbances and may be effectively treated with gabapentin.
PSH should not yet alter management in cardiogenic shock; this case leaves open a potential role for gabapentin.
Background Paroxysmal sympathetic hyperactivity (PSH) is characterized by excessive autonomic activation typically seen after severe brain injury. PSH has not previously been reported in association with cardiogenic shock. Here, we report a case of PSH during the treatment of cardiogenic shock with dilated cardiomyopathy. Case Presentation A 60‐year‐old man with cardiogenic shock and dilated cardiomyopathy was transferred to our hospital. He was intubated and received an Impella support. On Day 4 post‐admission, paroxysmal fever, tachycardia, tachypnea, and abnormal muscle tone were observed in the extremities. Antiepileptic drugs and broad‐spectrum antibiotics were ineffective, and the seizure pattern suggested PSH; therefore, gabapentin was started on Day 27 post‐admission. The seizures gradually resolved and eventually resolved. Conclusion This case suggests that PSH may be triggered by functional disturbances in cerebral perfusion and autonomic regulation associated with cardiogenic shock, even in the absence of irreversible brain injury. When patients with cardiogenic shock present with paroxysmal tachycardia, tachypnea, and fever, PSH should be considered in the differential diagnosis. Early recognition of PSH may facilitate timely treatment and contribute to improved clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Katsuyama et al. (2026) studied this question. Paroxysmal sympathetic hyperactivity can occur in cardiogenic shock without brain injury and resolves with gabapentin treatment, as observed in a 60-year-old patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: